Using real-time RT-PCR, the relative expression levels of BRD2, BRD3, and BRD4 were evaluated by the comparison of their expression in 39 pairs of RCC tissues and adjacent normal tissues. This evidence concerns the gene BRD4 and renal cell carcinoma.